123 related articles for article (PubMed ID: 6575727)
1. [Adriamycin-aclacinomycin therapy (AA therapy) for acute leukemia unresponsive to BH-AC-DMP therapy].
Kobayashi M; Tahara T
Gan To Kagaku Ryoho; 1983 Jun; 10(6):1473-9. PubMed ID: 6575727
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of acute non-lymphocytic leukemia with concurrent administration of N4-behenoyl-beta-D-arabinofuranosylcytosine, aclacinomycin A, 6-mercaptopurine and prednisolone; a pilot study (author's transl)].
Hirano M; Morishita Y; Ino T; Matsui T; Shimizu S; Shigemura H; Nakamura K; Ono Y; Saito M
Rinsho Ketsueki; 1981 Mar; 22(3):299-305. PubMed ID: 6944508
[No Abstract] [Full Text] [Related]
3. [Combination chemotherapy of N(4)-behenoyl-1-beta-arabinofuranosylcytosine, aclarubicin, 6-MP, and prednisolone (BH-AC. AMP therapy) for adult acute non-lymphocytic leukemia].
Ishige K; Takagi T; Oguro M
Gan To Kagaku Ryoho; 1984 Jul; 11(7):1475-9. PubMed ID: 6588925
[TBL] [Abstract][Full Text] [Related]
4. [Mucosal injury of aclacinomycin A in patients with adult acute leukemia--comparison of BH-AC. AMP therapy and BH-AC. DMP therapy].
Takeyama H; Kataoka T; Yano K; Fukutani H; Watanabe E
Rinsho Ketsueki; 1986 Apr; 27(4):508-13. PubMed ID: 3461186
[No Abstract] [Full Text] [Related]
5. [Comparative evaluation of combined chemotherapeutic regimens in acute non-lymphocytic leukemia].
Sasaki H; Maekawa I; Kawamura S; Miyake T
Hokkaido Igaku Zasshi; 1983 May; 58(3):271-8. PubMed ID: 6194091
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of acute myelogenous leukemia with concurrent administration of N4-behenoyl-ara-C, aclacinomycin A, 6-mercaptopurine and prednisolone].
Ino T; Saito M; Matsui T; Shimizu S; Shigemura H; Nakamura K; Ono Y; Okamoto M; Takada T; Imura H
Rinsho Ketsueki; 1985 Feb; 26(2):139-46. PubMed ID: 3860668
[No Abstract] [Full Text] [Related]
7. Nationwide randomized comparative study of daunorubicin and aclarubicin in combination with behenoyl cytosine arabinoside, 6-mercaptopurine, and prednisolone for previously untreated acute myeloid leukemia.
Nagura E; Kimura K; Yamada K; Ohta K; Maekawa T; Takaku F; Uchino H; Masaoka T; Amaki I; Kawashima K
Cancer Chemother Pharmacol; 1994; 34(1):23-9. PubMed ID: 8174198
[TBL] [Abstract][Full Text] [Related]
8. [Gastrointestinal symptoms of aclacinomycin A in patients with adult acute nonlymphocytic leukemia--comparison of BH-AC-DMP therapy and BH-AC-AMP therapy].
Kawano F; Tajima H; Matsuoka Y; Asou N; Takatsuki K
Rinsho Ketsueki; 1985 Apr; 26(4):494-8. PubMed ID: 3862889
[No Abstract] [Full Text] [Related]
9. [A case of acute promyelocytic leukemia complicated with severe esophageal stenosis caused by aclacinomycin A].
Kataoka T; Takeyama H; Watanabe E; Yano K
Gan To Kagaku Ryoho; 1985 Aug; 12(8):1686-9. PubMed ID: 3861136
[TBL] [Abstract][Full Text] [Related]
10. [ABEP chemotherapy in the treatment of advanced non-Hodgkin's lymphomas].
Yoshida T; Nakanishi J; Ito K; Kobayashi K; Ohtake S; Nakamura S; Matsuda T; Nakagoshi T; Natori K; Nakamura E
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):984-9. PubMed ID: 3963862
[TBL] [Abstract][Full Text] [Related]
11. Behenoyl cytosine arabinoside, aclacinomycin A, 6-mercaptopurine, and prednisolone combination therapy for acute non-lymphocytic leukaemia in adults.
Yoshida M; Suda K; Tsuboyama A; Sasaki R; Kitagawa S; Kano Y; Muto Y; Takaku F; Sakamoto S; Miura Y
Eur J Haematol; 1989 Jul; 43(1):1-6. PubMed ID: 2767238
[TBL] [Abstract][Full Text] [Related]
12. Aclacinomycin A and behenoyl arabinofuranosylcytosine combination chemotherapy for previously untreated acute leukemia.
Sampi K; Sakurai M; Kaneko Y; Hattori M
Oncology; 1986; 43(1):18-22. PubMed ID: 3455751
[TBL] [Abstract][Full Text] [Related]
13. [Aclacinomycin A and behenoyl ara-C combination chemotherapy for untreated acute non-lymphocytic leukemia].
Sampi K; Honda T; Hayashi Y; Hattori M
Gan To Kagaku Ryoho; 1983 Oct; 10(10):2211-6. PubMed ID: 6578705
[TBL] [Abstract][Full Text] [Related]
14. [BH-AC.AMP protocol in the treatment of refractory childhood acute leukemia].
Nakadate H; Hatayama Y; Hatae Y; Takeda T
Gan To Kagaku Ryoho; 1988 Oct; 15(10):2907-10. PubMed ID: 3178240
[TBL] [Abstract][Full Text] [Related]
15. [Remission induction by ACM-A and BH-AC on acute promyelocytic leukemia which is resistant to DNR and CA (author's transl)].
Shimazaki C; Nakajima Y; Ura Y; Hamami T; Haruyama H; Isemura T; Nakagawa M; Ijichi H
Rinsho Ketsueki; 1981 Jul; 22(7):1116-22. PubMed ID: 6948970
[No Abstract] [Full Text] [Related]
16. Treatment of acute non-lymphocytic leukemia with alternating non-cross resistant chemotherapy.
Kyo T; Dohy H
Nihon Ketsueki Gakkai Zasshi; 1988 Dec; 51(8):1641-52. PubMed ID: 3247827
[No Abstract] [Full Text] [Related]
17. [Comparative evaluation of a combination of daunorubicin and cytosine arabinoside and that of aclarubicin and cytosine arabinoside in remission induction in acute non-lymphocytic leukemia].
Takahashi I; Hara M; Ohmoto E; Oda Y; Endo Y; Fujimoto S; Uchida K; Takaoka K; Watanabe S; Lai M; Kohi F; Kitajima K; Kimura I; Sanada H; Tokioka M; Adachi T; Yorimitsu S
Gan To Kagaku Ryoho; 1982 Sep; 9(9):1617-22. PubMed ID: 6964050
[TBL] [Abstract][Full Text] [Related]
18. [Therapeutic results with aclacinomycin A in recurring acute leukemias].
Mitrou PS
Onkologie; 1983 Aug; 6(4):192-4. PubMed ID: 6355949
[TBL] [Abstract][Full Text] [Related]
19. Increasing aclarubicin dose in low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor (CAG regimen) is efficacious as salvage chemotherapy for relapsed/refractory mixed-phenotype acute leukemia.
Liu L; Qu Q; Jiao W; Zhang Y; Li X; Ding C; Wu D
Leuk Res; 2015 Aug; 39(8):805-11. PubMed ID: 26021434
[TBL] [Abstract][Full Text] [Related]
20. [Comparison of conventional chemotherapy and short-term intensive chemotherapy in adult acute myeloid leukemia].
Ohshima T
Rinsho Ketsueki; 1989 Aug; 30(8):1175-7. PubMed ID: 2601028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
